Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 457

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

Open access
Li, Wen, Liu, Ji-Bin, Hou, Li-Kun, Yu, Fei, Zhang, Jie, Wu, Wei, Tang, Xiao-Mei, Sun, Feng, Lu, Hai-Min, Deng, Jing, Bai, Jie, Li, Juan, Wu, Chun-Yan, Lin, Qin-Lu, Lv, Zhong-Wei, Wang, Gao-Ren, Jiang, Geng-Xi, Ma, Yu-Shui, Fu, Da · 2022 · Molecular Cancer

Abstract

Primary lung cancer is one of the most common malignant tumors in China. Approximately 60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is necessary to find new tumor markers for early diagnosis and individualized treatment. Tumor markers contribute to the early diagnosis of lung cancer and play important roles in early detection and treatment, as well as in precision medicine, efficacy monitoring, and prognosis prediction. The pathological diagnosis of lung cancer in small biopsy specimens determines whether there are tumor cells in the biopsy and tumor type. Because biopsy is traumatic and the compliance of patients with multiple biopsies is poor, liquid biopsy has become a hot research direction. Liquid biopsies are advantageous because they are nontraumatic, easy to obtain, reflect the overall state of the tumor, and allow for real-time monitoring. At present, liquid biopsies mainly include circulating tumor cells, circulating tumor DNA, exosomes, microRNA, circulating RNA, tumor platelets, and tumor endothelial cells. This review introduces the research progress and clinical application prospect of liquid biopsy technology for lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-022-01505-z

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Cited by

See all 457

Metadata

Authors
Li, W., Liu, J.-B., Hou, L.-K., Yu, F., Zhang, J., Wu, W., Tang, X.-M., Sun, F., Lu, H.-M., Deng, J., Bai, J., Li, J., Wu, C.-Y., Lin, Q.-L., Lv, Z.-W., Wang, G.-R., Jiang, G.-X., Ma, Y.-S., & Fu, D.
Venue
Molecular Cancer
Published
2022-01-20
Volume
21
Issue
1
Pages
25-25
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4206243212
Cited by
457
References
78
FWCI
31.72
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. https://app.cochat.ai/papers/10.1186/s12943-022-01505-z
The paper
Li, W., Liu, J.-B., Hou, L.-K., Yu, F., Zhang, J., Wu, W., Tang, X.-M., Sun, F., Lu, H.-M., Deng, J., Bai, J., Li, J., Wu, C.-Y., Lin, Q.-L., Lv, Z.-W., Wang, G.-R., Jiang, G.-X., Ma, Y.-S., & Fu, D. (2022). Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Molecular Cancer. https://doi.org/10.1186/s12943-022-01505-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.